Asian regulators agree on common goals in line with global trends
This article was originally published in Clinica
Regulators and industry representatives from five Asian nations have established a six-point working plan to advance regional harmonisation of device regulations.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.